Gidrolizin l-103

Roman name

Halrolysinum L-103

The registration

67/554/27

Of drugs

Protein drug injection (bypassing the digestive tract) nutrition; Also desintoksicirutee Effects (prints from the body harmful substances). _

Indications for use

Diseases associated protein deficiency (gipoproteinemia-reduced protein content in the blood), the depletion of the body intoxication (poisoning), and Radiation ojogwvaya disease failed granulirute (poorly healing), the wounds of the gastric and stomach.

Dosing and Administration

Intravenously and subcutaneously (in both cases drip); Through jeludochny probe (special tube). Intravenously and subcutaneously, as from 20 drops per minute. With good endurance to 40-60 drops per minute. Daily intake do 1.5-2 litres a day.

Side-effects and contraindications

Same as in the application aminotrofa.

Form of

The bottle of 450 ml.

Storage conditions

The temperature from 4 to 20 C.

Directory → Metaboliki → Funds for enteralnogo and parenteral nutrition → Gidrolizin l-103